Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery

Microneedles are minimally invasive systems that can deliver drugs intradermally without pain and bleeding and can advantageously replace the hypodermal needles and oral routes of delivery. Deferasirox (DFS) is an iron chelator employed in several ailments where iron overload plays an important role...

Full description

Saved in:
Bibliographic Details
Main Authors: Hafsa Shahid Faizi (Author), Lalitkumar K. Vora (Author), Muhammad Iqbal Nasiri (Author), Yu Wu (Author), Deepakkumar Mishra (Author), Qonita Kurnia Anjani (Author), Alejandro J. Paredes (Author), Raghu Raj Singh Thakur (Author), Muhammad Usman Minhas (Author), Ryan F. Donnelly (Author)
Format: Book
Published: MDPI AG, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9d96fbcde01c4917aecaa0f80c2971d2
042 |a dc 
100 1 0 |a Hafsa Shahid Faizi  |e author 
700 1 0 |a Lalitkumar K. Vora  |e author 
700 1 0 |a Muhammad Iqbal Nasiri  |e author 
700 1 0 |a Yu Wu  |e author 
700 1 0 |a Deepakkumar Mishra  |e author 
700 1 0 |a Qonita Kurnia Anjani  |e author 
700 1 0 |a Alejandro J. Paredes  |e author 
700 1 0 |a Raghu Raj Singh Thakur  |e author 
700 1 0 |a Muhammad Usman Minhas  |e author 
700 1 0 |a Ryan F. Donnelly  |e author 
245 0 0 |a Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery 
260 |b MDPI AG,   |c 2022-12-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14122817 
500 |a 1999-4923 
520 |a Microneedles are minimally invasive systems that can deliver drugs intradermally without pain and bleeding and can advantageously replace the hypodermal needles and oral routes of delivery. Deferasirox (DFS) is an iron chelator employed in several ailments where iron overload plays an important role in disease manifestation. In this study, DFS was formulated into a nanosuspension (NSs) through wet media milling employing PVA as a stabilizer and successfully loaded in polymeric dissolving microneedles (DMNs). The release studies for DFS-NS clearly showed a threefold increased dissolution rate compared to pure DFS. The mechanical characterization of DFS-NS-DMNs revealed that the system was sufficiently strong for efficacious skin penetration. Optical coherence tomography images confirmed an insertion of up to 378 µm into full-thickness porcine skin layers. The skin deposition studies showed 60% drug deposition from NS-DMN, which was much higher than from the DFS-NS transdermal patch (DFS-NS-TP) (without needles) or pure DFS-DMNs. Moreover, DFS-NS without DMNs did not deposit well inside the skin, indicating that DMNs played an important role in effectively delivering drugs inside the skin. Therefore, it is evident from the findings that loading DFS-NS into novel DMN devices can effectively deliver DFS transdermally. 
546 |a EN 
690 |a nanocrystals 
690 |a nanosuspension 
690 |a dissolving microneedles 
690 |a deferasirox 
690 |a intradermal delivery 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 12, p 2817 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/12/2817 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/9d96fbcde01c4917aecaa0f80c2971d2  |z Connect to this object online.